NCT07335003 2026-01-12
Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses
Cosmetique Active International
Phase NA Recruiting
Clinical Trials
53 trialsNCT07290959 2025-12-18
Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK
San Salvatore Hospital of L'Aquila
Phase NA Completed
NCT06008171 2025-04-04
Patient Decision Aid for the Treatment of Actinic Keratosis
Maastricht University Medical Center
Phase NA Active not recruiting
NCT03906253 2025-03-25
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
Wright State University
Phase NA Recruiting
NCT03066843 2025-01-31
Photodynamic Therapy Incubation Times for Actinic Keratosis
Northwestern University
Phase NA Active not recruiting
NCT05365386 2024-12-03
Efficacy and Safety of Tixel Treatment on Facial and/or Scalp Actinic Keratoses.
Novoxel Ltd.
Phase NA Completed
NCT06685588 2024-11-12
Efficacy of Topical 5-Fluorouracil Vs Calcipotriol As Photodynamic Therapy Pre-treatment for Field Actinic Keratoses
St Vincent's University Hospital, Ireland
Phase NA Not yet recruiting
NCT06507644 2024-10-15
Methyl Aminolevulinate 8% and 16% Incubated by 1 and 3 for Actinic Keratoses Treatment
University of Nove de Julho
Phase NA Not yet recruiting
NCT06476964 2024-07-08
StratiKA
University Hospital, Bordeaux
Phase NA Recruiting
NCT06274320 2024-06-18
Effect of Lipikar Urea 30% Before Actinic Keratoses Treatment
Cosmetique Active International
Phase NA Recruiting
NCT05937529 2024-05-08
Impact of Madecassoside and 5 % Panthenol Cream in Post Photodynamic Therapy for Actinic Keratosis
Bispebjerg Hospital
Phase NA Completed
NCT03246412 2024-03-07
Nevus Doctor Clinical Decision Support for GPs
University Hospital of North Norway
Phase NA Completed
NCT05456334 2023-11-21
New Treatments for Actinic Keratoses of the Scalp
Helsinki University Central Hospital
Phase NA Unknown
NCT05522036 2023-10-18
Dermaris-35
Centre Dermatologique du Roy
Phase NA Completed
NCT05356572 2023-10-10
A Pre-market Study to Evaluate the Performance and Safety of a Skin Preparation Device for Removal of Dry Crusty Skin
Mirka Ltd
Phase NA Completed
NCT00843323 2023-05-10
PDT
University of Sao Paulo
Phase NA Completed
NCT05152407 2021-12-30
MRB 0.3% Serum Effectiveness on 2 Early Clinical Markers of Photoinduced Cutaneous Aging: Actinic Lentigo and Actinic Keratosis
NAOS Institute of Life Science
Phase NA Unknown
NCT00558688 2021-12-06
A Photodynamic Therapy for Treatment of Actinic Keratoses
Northwestern University
Phase NA Completed
NCT00756288 2021-12-06
Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses
Northwestern University
Phase NA Withdrawn
NCT04779255 2021-09-29
ANTUKA
Poitiers University Hospital
Phase NA Unknown
NCT04527653 2021-06-04
Evaluation of The Efficacy and Safety of Tixel Treatment for the Treatment of Facial and/or Scalp Actinic Keratoses
Novoxel Ltd.
Phase NA Completed
NCT04759261 2021-02-18
SMAD4 Methylation and Expression Levels in Non-melanocytic Skin Cancers; SMAD4 Protein Positivity
Trakya University
Phase NA Unknown
NCT02867722 2021-02-01
DaylightPDT
Brigham and Women's Hospital
Phase NA Withdrawn
NCT02878382 2020-08-04
PDT
University of Sao Paulo
Phase NA Completed
NCT04396184 2020-05-20
Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Actinic Keratosis
Shanghai Dermatology Hospital
Phase NA Unknown
NCT03315286 2019-12-18
Validation of SHADE a Mobile Technology for Monitoring of Ultraviolet Exposure
Weill Medical College of Cornell University
Phase NA Completed
NCT02150863 2019-11-18
Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study
Massachusetts General Hospital
Phase NA Terminated
NCT02902822 2019-05-17
Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
Centro Studi Gised
Phase NA Completed
NCT03596619 2019-03-19
The Study of Plum-blossom Needling Enhancing Efficacy of Aminolevulinic Acid-photodynamic Therapy for Actinic Keratosis
Shanghai Dermatology Hospital
Phase NA Unknown
NCT00814528 2018-09-10
Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses
University of Chicago
Phase NA Withdrawn
NCT01444989 2018-08-15
AKRQ
Wake Forest University Health Sciences
Phase NA Completed
NCT03076918 2018-05-18
Flexithera
University Hospital, Lille
Phase NA Terminated
NCT03508856 2018-04-26
Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin
Skin Laser & Surgery Specialists
Phase NA Completed
NCT02938715 2018-01-16
Pilot Study of the Pragmatic Use of Mobile Phone Based Follow up of Actinic Keratoses Treated With Topical 5-fluorouracil
University of California, Davis
Phase NA Completed
NCT03076892 2017-11-14
PHOS-ISTOS
University Hospital, Lille
Phase NA Completed
NCT01898936 2017-10-09
Fractional Laser-assisted Daylight Photodynamic Therapy Versus Daylight Photodynamic for Treatment of Actinic Keratoses
Oslo University Hospital
Phase NA Completed
NCT02062853 2017-07-19
Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational Video
University of California, Davis
Phase NA Completed
NCT01812837 2017-06-15
The Use of Microneedles in Photodynamic Therapy
University of California, Davis
Phase NA Completed
NCT00524485 2017-06-14
Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis
Roswell Park Cancer Institute
Phase NA Terminated
NCT02644187 2017-05-10
Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol
Vastra Gotaland Region
Phase NA Completed
NCT02451579 2017-03-01
A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy
Goldman, Butterwick, Fitzpatrick and Groff
Phase NA Completed
NCT03013647 2017-01-06
Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization
University of Sao Paulo General Hospital
Phase NA Unknown
NCT02520700 2015-08-13
A Comparison of White-light and Daylight Topical Methyl 5-aminolaevulinic Acid Photodynamic Therapy for Actinic Keratoses
St Vincent's University Hospital, Ireland
Phase NA Completed
NCT01053000 2015-08-11
Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses
Stewart, Roger H., M.D., P.A.
Phase NA Completed
NCT00121511 2015-05-27
The Effect of Efudex Treatment on Photoaged Skin
University of Michigan
Phase NA Completed
NCT02325661 2014-12-25
AKQOLVS
University of Zurich
Phase NA Completed
NCT01905891 2014-11-19
Nanocytology Test to Evaluate Skin Cancer in High Risk Patients
Northwestern University
Phase NA Completed
NCT02242747 2014-09-17
Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic Keratosis
University of Sao Paulo
Phase NA Completed
NCT01541228 2013-09-04
Photodynamic Treatment of Actinic Keratoses With Different Light Doses
Lithuanian University of Health Sciences
Phase NA Completed
NCT01502020 2011-12-30
A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclaraâ„¢ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses
Actavis Mid-Atlantic LLC
Phase NA Completed